Latest Reports

THIS MONTH’S FEATURED ARTICLE

SMIL moves quickly to add NETSPOT® for NETs diagnostic imaging

Nishant Verma, MD

With the growing incidence of neuroendocrine tumors (NETs) and the significant differential in 5-year survival depending on early vs. late diagnosis, diagnostic imaging’s role in the identification and treatment of these rare tumors has taken on greater urgency. Read More.